Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Experimental Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07654933
What this trial is testing

Physiotherapy Effects on Function, Ambulation, and Independence in Palliative Cancer Care

Who this might be right for
Advanced CancerPalliative
University of Jazan 32
Not applicableStudy completedNCT06505538
What this trial is testing

Nurse-Led Mobile App Effect on Symptom Management for Breast Cancer Patients After Surgery

Who this might be right for
Symptom ManagementBreast Care NurseMobile App+1 more
Gümüşhane Universıty 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06928363
What this trial is testing

A First-in-human Study of KY-0301 in Patients With Advanced Solid Tumors.

Who this might be right for
Solid Tumors
Novatim Immune Therapeutics (Zhejiang) Co., Ltd. 212
Testing effectiveness (Phase 2)Study completedNCT01968109
What this trial is testing

An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors

Who this might be right for
Neoplasms by Site
Bristol-Myers Squibb 1,482
Early research (Phase 1)Looking for participantsNCT07646106
What this trial is testing

THE-0504 in Patients With Solid Tumors

Who this might be right for
Small Cell Lung Cancer (SCLC)Colorectal Carcinoma (CRC)Gastric Cancer (GC)+2 more
Thena Biotech S.r.l. 30
Not applicableNot Yet RecruitingNCT07662967
What this trial is testing

Feasibility and Preliminary Performance of an AI Prototype for Digital ROSE During EBUS-TBNA and Peripheral TBNA: a Prospective Pilot Study (AI-ROSE-FEAS)

Who this might be right for
Lung NeoplasmsBronchoscopyAI (Artificial Intelligence)+4 more
Azienda Ospedaliera di Rilievo Nazionale A.Cardarelli 65
Testing effectiveness (Phase 2)Ended earlyNCT03149549
What this trial is testing

PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors

Who this might be right for
Solid Tumor, AdultBreast CancerNon Small Cell Lung Cancer+2 more
CytomX Therapeutics 99
Testing effectiveness (Phase 2)Ended earlyNCT00373204
What this trial is testing

Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere)

Who this might be right for
Lung Cancer
Pharmacyclics LLC. 50
Early research (Phase 1)Study completedNCT00613665
What this trial is testing

Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults

Who this might be right for
Helicobacter PyloriGastritisGastric Cancer+2 more
Novartis Vaccines 113
Early research (Phase 1)Looking for participantsNCT04589624
What this trial is testing

An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy

Who this might be right for
Thyroid Gland Carcinoma
M.D. Anderson Cancer Center 42
Not applicableEnded earlyNCT03465579
What this trial is testing

Mp-3TMRI and 68Ga-PSMA PET/CT Guided Prostate Biopsy and Tumor Node Metastasis (TNM) Staging.

Who this might be right for
68Ga-PSMA PET/CT Guided Prostate BiopsyMp-3TMRI Guided Prostate BiopsyProstate Cancer+2 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 261
Testing effectiveness (Phase 2)Study completedNCT06029127
What this trial is testing

Gimistotug (BGB-A445) in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
BeiGene 35
Not applicableStudy completedNCT07474246
What this trial is testing

A Innovative Web-based Dance Movement Therapy

Who this might be right for
Breast Cancer
Chin-Tsung Shen 67
Testing effectiveness (Phase 2)Study completedNCT02598960
What this trial is testing

An Investigational Immuno-therapy Study of Experimental Medication BMS-986156, Given by Itself or in Combination With Nivolumab in Patients With Solid Cancers or Cancers That Have Spread.

Who this might be right for
Solid Tumors
Bristol-Myers Squibb 295
Not applicableActive Not RecruitingNCT06090162
What this trial is testing

LIBERTY: Liquid Biopsy to Diagnose and Monitor CNS Involvement in High-risk B Cell Non-Hodgkin Lymphoma

Who this might be right for
Non-hodgkin Lymphoma, B Cell
Swiss Cancer Institute 64
Not applicableStudy completedNCT03693378
What this trial is testing

IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups

Who this might be right for
Pancreatic Ductal AdenocarcinomaFamilial Pancreatic CancerFAMMM - Familial Atypical Mole Malignant Melanoma Syndrome
Immunovia, Inc. 1,349
Testing effectiveness (Phase 2)Study completedNCT00248404
What this trial is testing

NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS)

Who this might be right for
Tumors
Kiadis Pharma 155
Not applicableLooking for participantsNCT04165798
What this trial is testing

KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 1,065
Testing effectiveness (Phase 2)Looking for participantsNCT06780085
What this trial is testing

Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 96
Post-approval studies (Phase 4)Study completedNCT02596035
What this trial is testing

An Investigational Immuno-therapy Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 197
Next Page